Study to improve the quality of sarcopenia prevention strategies through effective nutritional therapy in elderly diabetic patients -An Observational Study to Identify Optimal Nutritional Status for the Prevention of Onset and Progression of Sarcopenia in Elderly Individuals with Diabetes-

Study to improve the quality of sarcopenia prevention strategies through effective nutritional therapy in elderly diabetic patients -An Observational Study to Identify Optimal Nutritional Status for the Prevention of Onset and Progression of Sarcopenia in Elderly Individuals with Diabetes- - Diabetes In Aging Muscle: Observation & Nutrition Dynamics in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058767

Enrollment

160

Registered

2025-09-01

Start date

2025-09-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosis: Patients diagnosed with type 2 diabetes mellitus 2) Age: Patients aged >=65 and <90 years at the time of consent 3) Sex: No restriction 4) Daily living status: Patients who are independent in activities of daily living and do not meet the criteria for "requiring long-term care" as defined by the Ministry of Health, Labour and Welfare in Japan 5) Medical care setting: Patients receiving outpatient or inpatient care in departments related to lifestyle-related diseases (e.g., internal medicine, diabetology, endocrinology and metabolism, general internal medicine, cardiology) 6) Informed consent: Patients who have provided written informed consent of their own free will, or patients for whom written consent has been obtained from a legally authorized representative

Exclusion criteria

Exclusion criteria: 1) Patients with type 1 diabetes mellitus 2) Patients with severe renal impairment (creatinine clearance <15 mL/min) 3) Patients with severe hepatic dysfunction (Child-Pugh class C) 4) Patients with acute complications, malignancies, or other serious illnesses 5) Patients who are unable to maintain a standing posture 6) Patients who meet the criteria for "requiring long-term care" as defined by the Ministry of Health, Labour and Welfare of Japan 7) Patients who have received steroid therapy or treatment for malignancy within the past 6 months 8) Patients deemed inappropriate for participation in this study by the principal investigator or co-investigators

Design outcomes

Primary

Measure	Time frame
Physical function (Five-Times Sit-to-Stand Test)	—

Secondary

Measure	Time frame
Total and appendicular skeletal muscle mass (assessed by bioelectrical impedance analysis [BIA]) Muscle strength (handgrip strength) Muscle quality (phase angle and bioelectrical impedance vector analysis [BIVA])	—

Countries

Japan

Contacts

Public ContactNoriko Satoh-Asahara

National Center for Geriatrics and Gerontology Department of Diabetes and Endocrinology

nsatoh@kuhp.kyoto-u.ac.jp0562-46-2311

Outcome results